ArriVent BioPharma, Inc. - Common Stock (NQ:AVBP)
29.13
-0.05
(-0.17%)
Streaming Delayed Price
Updated: 12:32 PM EDT, Aug 21, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 87,964 |
| Open | 29.45 |
| Bid (Size) | 29.08 (100) |
| Ask (Size) | 29.21 (700) |
| Prev. Close | 29.18 |
| Today's Range | 28.95 - 29.77 |
| 52wk Range | 17.00 - 35.83 |
| Shares Outstanding | 33,697,161 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Discover the 3 Best-Performing Biotech IPO Stocks of 2024
November 06, 2024
AVBP Stock Earnings: ArriVent BioPharma Misses EPS for Q2 2024 ↗
August 14, 2024
ProfoundBio Discovers The Joys Of Having A Wealthy Owner ↗
April 08, 2024
Frequently Asked Questions
Is ArriVent BioPharma, Inc. - Common Stock publicly traded?
Yes, ArriVent BioPharma, Inc. - Common Stock is publicly traded.
What exchange does ArriVent BioPharma, Inc. - Common Stock trade on?
ArriVent BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ArriVent BioPharma, Inc. - Common Stock?
The ticker symbol for ArriVent BioPharma, Inc. - Common Stock is AVBP on the Nasdaq Stock Market
What is the current price of ArriVent BioPharma, Inc. - Common Stock?
The current price of ArriVent BioPharma, Inc. - Common Stock is 29.13
When was ArriVent BioPharma, Inc. - Common Stock last traded?
The last trade of ArriVent BioPharma, Inc. - Common Stock was at 08/21/26 12:32 PM ET
What is the market capitalization of ArriVent BioPharma, Inc. - Common Stock?
The market capitalization of ArriVent BioPharma, Inc. - Common Stock is 981.60M
How many shares of ArriVent BioPharma, Inc. - Common Stock are outstanding?
ArriVent BioPharma, Inc. - Common Stock has 982M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.